KBS Research's Unattributed Round

KBS Research raised a round of funding on December 14, 2015.

KBS Research manufactures Atrantil, a new way to treat Irritable Bowel Syndrome without a prescription. Atrantil is a botanical extract that allows users to treat these common intestinal issues by att…

Articles about KBS Research's Unattributed Round: